Workflow
对标Neuralink,这款侵入式脑机接口明年有望临床 | 活力中国调研行
Di Yi Cai Jing·2025-06-19 15:20

Core Viewpoint - China has reached a world-leading level in semi-invasive brain-computer interface (BCI) technology, with invasive BCI technology also accelerating towards catching up, particularly in the medical field for patients with major motor disorders [1][2]. Group 1: Technology Development - The semi-invasive intelligent brain-computer system "Beijing Brain No. 1" has completed two batches of five human implants, showing initial recovery effects in subjects, and is preparing for formal clinical trials [1][7]. - "Beijing Brain No. 1" is the first international system to achieve over 100 channels, high throughput, wireless full implantation, and near-practical application [5]. - "Beijing Brain No. 2" has achieved the first international success in enabling a monkey to intercept a moving target using thought, with plans for clinical validation next year [10][11]. Group 2: Patient Impact - The initial focus for "Beijing Brain No. 1" is on patients with paralysis and speech disorders, with the potential to help restore communication abilities for speech-impaired patients [2][8]. - Among the five patients implanted, one with speech impairment has achieved a 63% accuracy in decoding 62 words, demonstrating the system's capability to assist in communication [8]. - The other four patients, suffering from various motor function disorders, have shown improvements in rehabilitation, such as enhanced muscle strength and the ability to control mechanical arms [8][9]. Group 3: Market and Competition - China has become the second country globally, after the United States, to enter the clinical trial phase for invasive BCI technology [2]. - The competitive landscape in China's invasive BCI market is expected to accelerate technological advancements, although there is still a gap compared to global leaders like Neuralink, which supports up to 1024 channels [12]. - The establishment of Beijing Brain Institute and the company Chip Intelligence is aimed at promoting the commercialization of BCI technologies and integrating resources for more effective research and development [4][12].